M&T Bank Corp grew its stake in shares of Waystar Holding Corp. (NASDAQ:WAY - Free Report) by 116.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,746 shares of the company's stock after purchasing an additional 34,316 shares during the period. M&T Bank Corp's holdings in Waystar were worth $1,778,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Ghisallo Capital Management LLC purchased a new stake in Waystar during the second quarter worth about $12,900,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Waystar during the 2nd quarter valued at approximately $27,950,000. Sculptor Capital LP purchased a new stake in shares of Waystar during the 2nd quarter worth approximately $791,000. Amalgamated Bank acquired a new stake in shares of Waystar in the 3rd quarter worth approximately $41,000. Finally, Point72 Asset Management L.P. increased its stake in Waystar by 154.1% in the 3rd quarter. Point72 Asset Management L.P. now owns 96,053 shares of the company's stock valued at $2,679,000 after purchasing an additional 58,253 shares in the last quarter.
Wall Street Analyst Weigh In
WAY has been the topic of a number of research analyst reports. Bank of America boosted their target price on Waystar from $27.00 to $32.00 and gave the stock a "buy" rating in a research report on Monday, October 14th. Evercore ISI increased their price objective on shares of Waystar from $32.00 to $36.00 and gave the company an "outperform" rating in a research note on Thursday, November 7th. Raymond James upgraded shares of Waystar from an "outperform" rating to a "strong-buy" rating and set a $40.00 target price for the company in a research report on Friday, November 22nd. JPMorgan Chase & Co. increased their price target on shares of Waystar from $24.00 to $27.00 and gave the company an "overweight" rating in a research report on Monday, August 19th. Finally, Royal Bank of Canada lifted their price objective on Waystar from $31.00 to $34.00 and gave the stock an "outperform" rating in a research report on Thursday, November 7th. Ten analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $32.90.
Read Our Latest Stock Analysis on Waystar
Waystar Stock Down 0.4 %
NASDAQ WAY traded down $0.12 during mid-day trading on Friday, reaching $34.07. 1,362,757 shares of the stock were exchanged, compared to its average volume of 1,156,208. The firm's fifty day simple moving average is $29.76. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.29 and a current ratio of 2.29. Waystar Holding Corp. has a 1-year low of $20.26 and a 1-year high of $34.60.
Waystar (NASDAQ:WAY - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.03. The business had revenue of $240.10 million for the quarter, compared to analyst estimates of $223.82 million. The business's revenue for the quarter was up 21.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Waystar Holding Corp. will post 0.03 earnings per share for the current year.
Waystar Company Profile
(
Free Report)
Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.
Further Reading
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.